ACUTAASNSEQ1 FY26July 30, 2025

Acutaas Chemicals Limited

1,706words
1turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
J2007PLC051093 July 30, 2025 To, The Listing Department, BSE LIMITED, Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai- 400 001 To, The Listing Department National Stock Exchange of India
77744 %
Srivastava Company Secretary & Compliance Officer Encl: Presentation +9175730 15366, +9172279 77744 % info@acutaas.com # www.acutaas.com Q@ Registered Office: Plot No. 440/4, 5 & 6, Road No. 82/A,
17.3%
irector “I am happy to share that we've had a strong start to FY26, with Q1 revenue growing 17.3% vyear-on-year, driven by robust performance in our Pharmaceutical Intermediates business.
25%
emicals, and semiconductors, we step into FY26 with strong momentum and confidence to deliver 25% growth with improved margins.” July 2025 Revenue to PAT Bridge ACUTAAS You and s chomisn’s
53.2%
Profit Employee Cost Other expenses EBITDA D&A PBIT Finance costs Other Income 53.2% 24.6% 581 PBT — 440 Tax Expense PAT 21.2% FY25 -1,023 . ETT | 205 743 Reve
24.6%
Employee Cost Other expenses EBITDA D&A PBIT Finance costs Other Income 53.2% 24.6% 581 PBT — 440 Tax Expense PAT 21.2% FY25 -1,023 . ETT | 205 743 Revenue fro
21.2%
PBIT Finance costs Other Income 53.2% 24.6% 581 PBT — 440 Tax Expense PAT 21.2% FY25 -1,023 . ETT | 205 743 Revenue from Operations COGS Gross Profit Employee
42.1%
Revenue from Operations COGS Gross Profit Employee Cost 2 [l EBITDA Other expenses 42.1% 16.7% 233 T B T Finance PBIT D&A costs - Other Income Eamings Presentation | July 2
16.7%
from Operations COGS Gross Profit Employee Cost 2 [l EBITDA Other expenses 42.1% 16.7% 233 T B T Finance PBIT D&A costs - Other Income Eamings Presentation | July 2025 o0
8.3%
- Other Income Eamings Presentation | July 2025 o0 s . T e Tax Expense PAT PBT 8.3% A\\ Q1 FY26 Financial Performance — Key Metrics ACUTAAS You and us chemistrys apex Revenue
23.3%
rmance — Key Metrics ACUTAAS You and us chemistrys apex Revenue from Operations YoY Growth 23.3% (1.8%) (Mn) > 17.3% 2,072 Q1 FY26 Earnings & Business Highlights Robust growth in Adv
1.8%
Key Metrics ACUTAAS You and us chemistrys apex Revenue from Operations YoY Growth 23.3% (1.8%) (Mn) > 17.3% 2,072 Q1 FY26 Earnings & Business Highlights Robust growth in Advanced Ph
Speaking time
For more information please contact
1
Advertisement
Opening remarks
For more information please contact
Acutaas Chemicals Limited Ekta Srivastava Company Secretary & Compliance Officer Cs @acutaascom Rahul Thakur Senior Manager - Investor Relations Rahul.thakur@acutaas.com %/ www.acutaas.com
Advertisement
← All transcriptsACUTAAS stock page →